Synergis Software launches advanced version of Adept Technology
Category: #tech  By Mateen Dalal  Date: 2019-11-06
  • share
  • Twitter
  • Facebook
  • LinkedIn

Synergis Software launches advanced version of Adept Technology

Synergis Software, a division of Synergis Technologies, recently held its fourth annual Adept Experience Conference, which witnessed participation of major business leaders. Reportedly, the conference gave an insight about breakthrough developments in the company’s flagship engineering information management solution, Synergis Adept, that aids in managing, sharing, securing of engineering & business documents.

The firm’s engineering information management solution was first introduced  to manage the complex relationships between CAD files and render innovative file searching capabilities for improving productivity within engineering teams. However, it has evolved to become a global solution that is capable of integrating with other software solutions such as MRP, ERP, CMMS, and Quality, stated Kristen Tomasic, president of Synergis Technologies, stated Kristen Tomasic, President of Synergis Technologies.

Synergis Adept aids organizations to improve workflow & collaboration, accelerate project startup, secure their IP, simplify compliance with industry regulations, streamline engineering change processes, avoid outages and shutdowns.

President Kristen Tomasic further revealed that Synergis Adept has saved time, money & workforce resources of many companies ever since it was incorporated in 1991.

Scott Lamond, V.P., Synergis Software, was reportedly quoted saying that Synergis Adept provides additional security against theft and saves billions of dollars in lost or stolen assets. Currently, more than 75,000 people manage their capital projects, property data, engineering as well as product data, which collectively worth around USD150 billion with Synergis Adept,”

Lamond added that Adept 2019 is a landmark release that strengthens the solution as an enterprise application and meets the demanding security standards of IT departments and also adds value for users in every department irrespective of what information they need to find, manage, share & secure.

Among various attendees of the conference, leaders from Leatherman, Con Edison, and Dow Chemical were a few to testify how Synergis Adept has aided them in profit generation and business expansion.

 

Source Credit: https://picante.today/technology/2019/11/06/107311/synergis-software-announces-global-launch-of-adept-technology-powered-to-transform-global-businesses/

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Arranta Bio acquires Captozyme to accelerate microbiome development
Arranta Bio acquires Captozyme to accelerate microbiome development
By Mateen Dalal

Arranta has established a Center of Excellence for microbiome development   The acquisition will help quicken the delivery of LBPs for clients worldwide Arranta Bio, a leading Contract Development Manufacturing Organization, recently annou...

CytoDyn obtains IRB approval for leronlimab for patients with TNBC
CytoDyn obtains IRB approval for leronlimab for patients with TNBC
By Mateen Dalal

Reports confirm that CytoDyn Inc., a late-stage biotechnology company has announced that it has recently received approval from the Institutional Review Board for leronlimab, to be directed to triple-negative breast cancer (TNBC) patients under a com...

FDA declines approval of Lipocine’s oral drug Tlando for third time
FDA declines approval of Lipocine’s oral drug Tlando for third time
By Mateen Dalal

FDA declines approval of Lipocine’s oral drug Tlando for third time Reportedly, the oral drug Tlando was first declined  approval by FDA in the year 2016. The U.S. Food and Drug Administration (FDA)  declined the approval of oral dr...